Status:
COMPLETED
Women's Estrogen/Progestin Lipid Lowering Hormone Atherosclerosis Regression Trial (WELL-HART)
Lead Sponsor:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Cardiovascular Diseases
Coronary Disease
Eligibility:
FEMALE
45-75 years
Phase:
PHASE3
Brief Summary
To determine the effects, in postmenopausal women, of hormone replacement therapy on progression/regression of coronary heart disease, as measured by quantitative angiography.
Detailed Description
BACKGROUND: The trial was a logical extension of preceding observational and cross-sectional studies on estrogen replacement therapy. Overall, the studies suggested a 50 percent reduction in risk of ...
Eligibility Criteria
Postmenopausal women with angiographically-documented coronary disease. Approximately 70 percent minority
Key Trial Info
Start Date :
March 1 1995
Trial Type :
INTERVENTIONAL
End Date :
August 1 2001
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00000559
Start Date
March 1 1995
End Date
August 1 2001
Last Update
July 12 2016
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.